|
COPYRIGHT 2002 International Medical News Group
MORAN, WYO. -- A fasting plasma homocysteine level of 10 [micro]mol/L or less ought to be the target in patients with known coronary disease, Dr. H. Robert Superko said at a meeting sponsored by the American College of Cardiology.
The rationale for this stringent goal--levels of 14 or 15 [micro]mol/L are now recommended--is based on an as-yet-unpublished study by Dr. Superko, director of the Cholesterol, Genetics, and Heart Disease Institute in San Mateo, Calif., and his associates.
They analyzed...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
